The use of antimicrobials in global pig production: A systematic review of methods for quantification. by Lekagul, Angkana et al.
LSHTM Research Online
Lekagul, A; Tangcharoensathien, V; Yeung, Shunmay; (2018) The use of antimicrobials in global pig
production: A systematic review of methods for quantification. Preventive veterinary medicine, 160.
pp. 85-98. ISSN 0167-5877 DOI: https://doi.org/10.1016/j.prevetmed.2018.09.016
Downloaded from: http://researchonline.lshtm.ac.uk/id/eprint/4649449/
DOI: https://doi.org/10.1016/j.prevetmed.2018.09.016
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
https://researchonline.lshtm.ac.uk
Accepted Manuscript
Title: The use of antimicrobials in global pig production: a
systematic review of methods for quantification
Authors: Angkana Lekagul, Viroj Tangcharoensathien,
Shunmay Yeung
PII: S0167-5877(18)30210-1
DOI: https://doi.org/10.1016/j.prevetmed.2018.09.016
Reference: PREVET 4542
To appear in: PREVET
Received date: 17-3-2018
Revised date: 27-8-2018
Accepted date: 16-9-2018
Please cite this article as: Lekagul A, Tangcharoensathien V, Yeung S,
The use of antimicrobials in global pig production: a systematic review
of methods for quantification, Preventive Veterinary Medicine (2018),
https://doi.org/10.1016/j.prevetmed.2018.09.016
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
Review articles: Preventive Veterinary Medicine 
The use of antimicrobials in global pig production: a systematic review of 
methods for quantification  
 
 
Angkana Lekagul,a, b, Viroj Tangcharoensathienb, Shunmay Yeunga 
 
 
a London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK. 
b International Health Policy Programme, Ministry of Public Health, Nonthaburi 11000, Thailand. 
 
 
 
Background 
 
Antimicrobial Resistance (AMR) is an increasingly serious threat to global public health. Overuse of 
antimicrobials can accelerate the emergence of antimicrobial resistance (World Health Organization, 
2015b). In livestock industries, large amounts of antimicrobials are used for both therapeutic and 
non-therapeutic purposes including growth promotion (Aarestrup, 2005). In response to global 
concerns about AMR, in 2008, the World Organization for Animal Health (OIE) launched guidelines 
on the prudent use of antimicrobials in veterinary medicines, which describes the respective 
responsibilities of relevant stakeholders such as veterinarians, regulators, pharmaceutical industries, 
animal producers and consumers (World Organisation for Animal Health (OIE), 2008).  
Measuring antimicrobial use is critical to understanding the magnitude and profile of antimicrobial 
resistance in countries.  Measurement is the first step to detecting whether there is excessive and 
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inappropriate use and monitoring whether policies aimed at optimising use are successful. 
Recognising this, international organizations such as FAO, OIE and WHO, have recommended that 
countries develop systems for monitoring antimicrobial consumption (World Health Organization, 
2015a, OIE, 2016, FAO, 2016). The World Health Organization (WHO) guidelines defines 
antimicrobial “consumption” data captured from aggregate sales data such as form importer, local 
manufacturer or wholesales,  whilst data on antimicrobial “use” are collected from patient-level data 
such as medical records and prescriptions (World Health Organization, 2017). Whilst there has been 
significant progress in the monitoring of antimicrobial use and consumption in the human health 
sector, action in the animal health sector has lagged behind (Schar et al., 2018).  Some European 
countries established national programs for the surveillance of antimicrobial consumption in animals 
for more than 20 years ago, specifically DANMAP in Denmark in 1995 (Statens Serum Institut, 2012), 
MARAN in Netherlands in 1998 (Anonymous, 2012) and SWEDRES-SVARM (SWEDRES and 
SVARM, 2014). The European Medicines Agency established the European Surveillance of 
Veterinary Antimicrobial Consumption (ESVAC) project in 2009(Agency, 2017) . ESVAC compiles, 
verifies and reports on antimicrobial consumption of veterinary antimicrobial agents in 29 European 
countries. Data are collected through a network of national focal points. Furthermore, ESVAC has 
been striving to set up a standardised methodology to allow for cross country comparisons. The 
monitoring of antimicrobial consumption serves various objectives. It monitors time trends of 
antimicrobial use, compares use by different antimicrobial classes, identifies high users and 
promotes more prudent use, and studies the association between level of usage and bacterial 
resistance (Collineau et al., 2017). 
Currently, there is a wide variation in the availability and type of data, methods and use 
measurement across countries. The lack of uniformity hampers cross-country comparisons(Collineau 
et al., 2017). In order to guide the strengthening of existing monitoring systems and the 
development of new ones to facilitate cross-country comparisons, it is essential to understand the 
different existing methods, their strengths, limitations and operational feasibility.  
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 This systematic review will describe and compare methods and measurement to quantify 
antimicrobial use in pigs, in order to contribute to the process of future guideline development of 
monitoring the antimicrobial use.  
 
Abbreviations  
ADD  Animal Daily Dose   
ADDD   Animal Defined Daily Dose  
AMR  Antimicrobial Resistance 
CASP  Critical Appraisal Skills Programme 
DADD   Defined Animal Daily Dosage 
DDD  Defined Daily Dose  
DDDA   Daily Doses Animal 
DDDvet  Defined Daily Dose  
DCDvet  Defined Course Dose 
DPD  Daily Product Dose 
EMA  European Medicines Agency 
ESVAC  European Surveillance of Veterinary Antimicrobial Consumption 
FAO   Food and Agriculture Organization  
nDDay   Daily Dose per animal year 
OIE  Organization for Animal Health  
PCU  Population Correction Unit 
PDD   Prescribed Daily Dose 
PrDD   Product-related Daily Doses 
TI  Treatment incidence 
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UDD   Used Daily Dose  
WHO  World Health Organisation 
 
 
Method 
Scope of study and research question 
The operational definitions of the terms used in this review are as follows.  
 
Term  Definition  
Antimicrobials According to OIE definition, an antimicrobial is considered as a naturally 
occurring, semi-synthetic or synthetic substance that exhibits antimicrobial 
activity (it kills or inhibits the growth of micro-organisms) at concentrations 
attainable in vivo. Anti-helminthic and substances classed as disinfectants or 
antiseptics are excluded from this definition (World Organisation for Animal 
Health (OIE), 2015).  
Pig The term refers to all stages of swine production including breeding and 
gestation, farrowing (from birth to weaning), nursery and feeding and 
finishing.  
Use and consumption As explained above WHO defines “use” data as estimates derived from 
patient-level data. It may focus on how and why antimicrobials are being used 
by health care providers and patients. “Consumption” data are usually 
reported when information on antimicrobial use in patients is not available. It 
can be collected from several sources such as import data, wholesale data or 
aggregated health insurance data. Consumption data provides a proxy 
estimate of the use of antimicrobials (World Health Organization, 2017).  
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However, in this study, for simplicity the term “use” is applied to refer to both 
use at farm level and consumption at aggregate national or sub-national level. 
Biomass  The weight or total quantity of living organisms of one animal species or of all 
the species in the community. Using biomass for antimicrobial consumption 
aims to compare the weight of animals between different species and 
between human and animals.  
 
This review covers use of antimicrobials in pigs, with the following research question: “What 
methods and measurements are used to quantify the use of antimicrobials?” 
Search strategy 
o SPIDER tool  
A “SPIDER” tool was applied in order to specifically identify relevant quantitative and mixed-
method studies. It covers the Sample, Phenomenon of interest, Design, Evaluation and Research 
type) (Cooke et al., 2012).  
S:   1) Surveys based on end-point antimicrobial usage: veterinary prescription, usage by pig 
farmer  
  2) Antimicrobial sales data (from pharmaceutical operators, such as importer,  
  manufacturer, wholesaler) 
P and I:  Antimicrobial use in pigs 
D:    Observational studies, intervention studies 
E:    Methods used for the measurement of antimicrobial use   
R:   Quantitative study 
 
o Eligibility assessment of studies and inclusion criteria 
The following inclusion criteria were considered:  
(i) the paper was published in, or translated into, the English language, 
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(ii) the study involved pigs of any age and type of production, 
(iii) the study provided quantitative data on antimicrobial use with a focus or clear explanation 
of the methodology in pigs or other food producing animals including pigs, 
(iv) The study had moderate to high ranking of a quality assessment. 
 
o Search protocol 
Literature on the use of antimicrobials in pigs was systematically reviewed between May to 
August 2017. Relevant scientific papers published in English peer-reviewed journal were identified 
using the keywords combinations in the title, abstract and content. All search terms were combined, 
see table 1.  
<Table 1> 
 
- Structured Database Search   
Online electronic databases were searched in English language literature with restriction of the 
date of publication being after 2000: MEDLINE (http://ovidsp.tx.ovid.com; 1946 until present), 
ScienceDirect (http://www.sciencedirect.com; 1996 until present), Scopus 
(http://www.scopus.com; 1823 until present) and Web of Science 
(http://apps.webofknowledge.com; 1970 until present). The initial scope of the search focused 
on low- and middle-income countries. Due to the limited number of publications, it was 
expanded to cover studies in high-income countries. 
- Grey literature 
 In addition to the structured database searches, articles were sourced through searches from 
the reference lists of key articles identified as in line with the research questions and inclusion 
criteria. This combination ensured that a wide range of articles from different sources was 
retrieved. 
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o Screening relevant records 
After the searches, the duplicate studies and inconsistencies between titles, abstracts and 
keywords were removed. Then, full texts were reviewed; those which were reviews, clinical 
research, pharmacokinetic, biopharmaceutical studies and laboratory studies were excluded.  
 
Studies were excluded for the following reasons: 
- No report on pattern or volume of antimicrobial use in pigs 
- Inappropriate study design: such as review, clinical research, pharmacokinetic and 
biopharmaceutical studies    
- Focus on laboratory study, on human health or antimicrobial activity, relationship with AMR, 
specific disease related to drug recommendation 
- Measurements of antimicrobial levels in farm waste, faeces and environment, residue in 
animal products 
- Low level of quality from assessment (<50%) 
 
Quality assessment  
The methodological quality of the studies was assessed using an instrument adapted from the 
Critical Appraisal Skills Programme (CASP) (Critical Appraisal Skills Programme (CASP), 2014). The 
four criteria of quality assessment were a) aim, b) method, c) result and d) application. The answer 
to the four criteria are either ‘yes’, or ‘no’ or ‘cannot tell’. Each criterion has certain a number of 
sub-criteria, there were in total eleven sub-criteria for quality assessment; see Table A2 (annex). If 
the assessment by the two independent reviewers (AS and VT) was ‘no’ or ‘cannot tell’, the score for 
that question was zero; the score for yes was one. When there were conflicting views, the reviewers 
discussed and sought consensus. In this review, the studies were ranked by quality criteria. The 
quality ranking was classified into three groups: High meant >75% of all eleven sub-criteria were 
met, moderate meats 50-75% were met, weak meant <50% were met. 
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 Data extraction and synthesis 
The full text of all relevant articles was reviewed and summarised using a standardised data 
extraction table in Excel which supported the sifting, sorting and annotation of primary source 
materials and data. Data extraction was categorized by three sets of variables: a) context variables: 
author, year of publication, year of study, title, journal, geographical area, objective and b) 
methodology variables: type of study, data source, sampling technique, sample size, methods for 
antimicrobial use measurement. See table A1 in annex for variables assessed in the study. 
 
Results  
Search processes  
The search from the four database and hand search identified 2,362 articles. After screening and 
removal of duplications, 90 manuscripts remained for further screening. Of these 90 manuscripts, 37 
manuscripts were selected on the basis of the inclusion criteria. Of these 37 manuscripts, seven 
articles described antimicrobials without essential information on the pattern or volume of 
antimicrobials use; these were excluded. Two articles were not included, because they were review 
articles. Another three articles were excluded as they only focused on the association between 
specific groups of antimicrobial and AMR.  No studies were excluded due to low rank of quality 
assessment (<50%). In summary, a total of 12 studies were excluded from the set of 37 studies, 
leaving 25 manuscripts that met the inclusion criteria and were included in this systematic review.  
 
< Figure 1>  
 
Description of the studies  
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Of the 25 studies, 22 studies were published between 2010 and 2016, with the remaining three 
being published between 2000 and 2010.  One study analysed global level use data and the others 
reported data from 12 countries.  Twenty studies were from eight European countries of which six 
were conducted in Denmark; two were multi-country studies; one study in Belgium, France, 
Germany and Sweden, and the other included Denmark and Netherlands. Two studies were 
conducted in African countries (South Africa and Kenya). Another two studies reported data from 
China and Japan. See table 2 for characteristic of these studies.  
 
<Table 2> 
 
The quality assessment is reported in table A2 of the Annex. In general, the hypotheses and the 
objectives of the study were clearly described. Fifteen (60%) studies were ranked as high quality 
(meeting more than 75% of all eleven sub-criteria). Ten remaining studies were of moderate quality. 
None had low quality assessment.  
 
Methods for measuring antimicrobial use  
A large variation in terms of the methodological approaches and units of measurement of 
antimicrobial use was found.   
 
1. Types of studies and data sources  
As shown in table 2, eight studies were primarily methodological, for example comparing 
antimicrobial use by using different methods or variables (Carmo et al., 2017, Dupont et al., 2016, 
Taverne et al., 2015, Trauffler et al., 2014a, Bondt et al., 2013, Timmerman et al., 2006) or 
developing new methodologies (Ferner et al., 2014, van Rennings et al., 2015). Twelve studies aimed 
to estimate antimicrobial use (Jensen et al., 2004, Mitema et al., 2001b, Sjolund et al., 2016, 
Krishnasamy et al., 2015, Sjolund et al., 2015, Van Boeckel et al., 2015, Hauck et al., 2014, Hosoi et 
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al., 2014, Bos et al., 2013, Callens et al., 2012, Eagar et al., 2012, Merle et al., 2012). One study 
examined both improving the national surveillance and measuring the antimicrobial use (Filippitzi et 
al., 2014). The remainder of studies assessed the association between the use of antimicrobials and 
farm management practice (Fertner et al., 2015, Vieira et al., 2011, Arnold et al., 2004). 
 
Eleven studies (44%) presented data at national level (Carmo et al., 2017, Dupont et al., 2016, 
Krishnasamy et al., 2015, Van Boeckel et al., 2015, Filippitzi et al., 2014, Hauck et al., 2014, Hosoi et 
al., 2014, Bondt et al., 2013, Jensen et al., 2012, Eagar et al., 2012, Mitema et al., 2001b). Fourteen 
studies (56%) presented data at sample farm level (Sjolund et al., 2016, Fertner et al., 2015, van 
Rennings et al., 2015, Sjolund et al., 2015, Taverne et al., 2015, Ferner et al., 2014, Trauffler et al., 
2014a, Trauffler et al., 2014b, Bos et al., 2013, Callens et al., 2012, Merle et al., 2012, Vieira et al., 
2011, Timmerman et al., 2006, Arnold et al., 2004) with four of these studies complete farm data at 
a national level (Sjolund et al., 2016, Taverne et al., 2015, Bos et al., 2013, Vieira et al., 2011). 
 
Data on antimicrobial use were collected from various sources. Of 25 studies, seven collected data 
through farm surveys (Sjolund et al., 2016, Sjolund et al., 2015, Ferner et al., 2014, Trauffler et al., 
2014a, Trauffler et al., 2014b, Callens et al., 2012, Timmerman et al., 2006), six compiled national 
data from the surveillance of antimicrobial consumption(Carmo et al., 2017, Dupont et al., 2016, 
Taverne et al., 2015, Van Boeckel et al., 2015, Filippitzi et al., 2014, Bondt et al., 2013, Vieira et al., 
2011), four collected data through veterinary prescriptions (Fertner et al., 2015, Bos et al., 2013, 
Jensen et al., 2012, Arnold et al., 2004), and four from a review of sales of pharmaceutical products 
(Carmo et al., 2017, Hauck et al., 2014, Hosoi et al., 2014, Eagar et al., 2012, Mitema et al., 2001b). 
Three studies drew information from more than one data source (van Rennings et al., 2015, Filippitzi 
et al., 2014, Merle et al., 2012) and one study used data on food animal antimicrobial utilization 
from the US, estimating the quantity of antimicrobials used in China (Krishnasamy et al., 2015).  
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Twenty-two studies (88%) reported antimicrobial use by major classes, while three studies (12%) 
reported in aggregation all classes of antimicrobial (Ferner et al., 2014, Fertner et al., 2015, Van 
Boeckel et al., 2015). Twenty studies (80%) reported the use of antimicrobials specific to pigs or 
other animal species but five studies (20%) only reported total use in all animal species (Van Boeckel 
et al., 2015, Ferner et al., 2014, Hauck et al., 2014, Eagar et al., 2012, Mitema et al., 2001a). 
 
2. Numerators: the amount of antimicrobial use  
Measuring numerators varied greatly, for example, by milligrams or kilograms of active ingredient 
and other more sophisticated adjustments such as defined daily dose, daily product dose, animal 
daily dose, used daily dose, prescribed daily dose, (see detail in Figure 2).   
 
3. Denominators: the number or mass of animals 
For denominator data, eight studies used national level animal population which was retrieved from 
government agencies such as National Statistics, Central registry for livestock (Carmo et al., 2017, 
Dupont et al., 2016, Taverne et al., 2015, Filippitzi et al., 2014, Hosoi et al., 2014, Bondt et al., 2013, 
Jensen et al., 2012, Vieira et al., 2011). Two studies applied data from the Food and Agriculture 
Organization (FAOSTAT) (Krishnasamy et al., 2015, Van Boeckel et al., 2015). For the twelve studies 
at farm level, the number of animals reported by a certain production type and the time period 
during the study period (Sjolund et al., 2016, Fertner et al., 2015, van Rennings et al., 2015, Sjolund 
et al., 2015, Ferner et al., 2014, Trauffler et al., 2014a, Trauffler et al., 2014b, Bos et al., 2013, Callens 
et al., 2012, Merle et al., 2012, Timmerman et al., 2006, Arnold et al., 2004). 
Several studies applied different standard weights for animal (Carmo et al., 2017). For example, the 
weights of an animal at treatment in Denmark (32) were: weaner 15 kilograms, slaughtered pig 50 
kilograms and sows 200 kilograms. In Austria (26) weights were: piglets 1.5-10 kilograms, weaners 
10-30 kilograms, fattened pigs <60 kilograms, and sow and boar > 60 kilograms. In Sweden (18) 
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weights were: sucking piglets 7 kilograms, weaners 7 kilograms, fatteners 35 kilograms and adult 
pigs 220 kilograms (Sjolund et al., 2015). 
 
4. Unit of measurement: indicators used   
Of the total 25 studies, there were ten different units of measurement. Nine studies calculated the 
total volume of antimicrobials used in the country per year (Carmo et al., 2017, Krishnasamy et al., 
2015, van Rennings et al., 2015, Ferner et al., 2014, Filippitzi et al., 2014, Hauck et al., 2014, Eagar et 
al., 2012, Merle et al., 2012, Mitema et al., 2001b). Five of these studies (Hauck et al., 2014, Merle et 
al., 2012, Mitema et al., 2001b, Carmo et al., 2017, Filippitzi et al., 2014) calculated the volume of 
antimicrobial substances by multiplying the number of packages (package size) with the potency 
(strength of active substance) for each antimicrobial. One study (Eagar et al., 2012) calculated the 
volume of antimicrobials in kilograms of active pharmaceutical ingredient from the reports provided 
by pharmaceutical companies, while two other studies (van Rennings et al., 2015), (Ferner et al., 
2014) used treatment data at the farms. Only one study attempted to estimate non-therapeutic 
antimicrobial use in livestock. This was done by multiplying the number of animals in different 
phases of production by the estimated feed consumed per day and the duration in days in each 
phase that the swine received antimicrobials through feed and doses of antimicrobials in the feed 
(Krishnasamy et al., 2015).   
 
 
4.1 Antimicrobials use measured by milligrams of active substance per animal weight 
Six studies used some measure of the biomass of animals in order to indicate the intensity of 
antimicrobial use (Carmo et al., 2017, Van Boeckel et al., 2015, Filippitzi et al., 2014, Hosoi et al., 
2014, Trauffler et al., 2014a, Trauffler et al., 2014b). Biomass is the total weight of live animals. Two 
studies (Trauffler et al., 2014a, Trauffler et al., 2014b) calculated biomass at farms by multiplying the 
number of animals and the average weight. One study estimated biomass by using the carcass 
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weight, which is the whole-body weight of a slaughtered animal after blood is drained, evisceration 
and skinning (Hosoi et al., 2014).  
 
Biomass can be calculated by using a population correction units (PCU). The PCU provides a better 
measurement of animal weight exposed to antimicrobial treatment: one PCU is equivalent to one 
kilogram of biomass of live animal or slaughtered animals where the animal had been exposed to 
antimicrobials throughout their lifecycle. For example, gross weight at slaughter was 150 kilograms, 
but the PCU was 65 kilograms and 25 kilograms for slaughtered and fattening pigs (Agency, 2013). 
Two studies (Carmo et al., 2017, Filippitzi et al., 2014) calculated the total national PCU, with 
reference to the guidelines produced by ESVAC, by multiplying the numbers of livestock animals and 
slaughtered animals by the theoretical weight at the time they were exposed to antimicrobial 
treatment.  Another study estimated the PCU by multiplying the numbers of live animals in a 
production period and a ratio of carcass weight to live weight of animals (Van Boeckel et al., 2015).  
 
4.2 Antimicrobials use measured by daily dose per weight at treatment 
The daily dosage is a measure of the amount of a specific active pharmaceutical ingredient (e.g. in 
milligrams) required to treat one kilogram of animal in one day with that antimicrobial preparation, 
and is based on the average dosage of a medicine per kilogram per day for a specific type of animal. 
 
Defined Daily Dose (DDD) is a technical unit of measurement of antimicrobial consumption in 
humans, calculated by standard DDD-value. In animals, measuring antimicrobial by defined daily 
dosage is calculated by using a specified dose of medicine (Animal Daily Dose value (ADD-value)), so 
called Animal Daily Dose (ADD) (Dupont et al., 2016, Fertner et al., 2015, Taverne et al., 2015, Ferner 
et al., 2014, Trauffler et al., 2014a, Trauffler et al., 2014b, Bondt et al., 2013, Jensen et al., 2012) or 
by using the mean authorised dosage (Taverne et al., 2015, Bos et al., 2013, Merle et al., 2012) so 
called Daily Doses Animal (DDDA).  
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 The ADD-value is specifically defined as the average maintenance dose per day for a drug used for its 
main indication for each animal species. The ADD-value was used in Denmark and Austria. They 
were based on the dose recommendations of each medicinal product registered in a country for 
each antimicrobial agent, administration route and animal species and when appropriate, also age 
group (Dupont et al., 2016, Fertner et al., 2015, Taverne et al., 2015, Ferner et al., 2014, Trauffler et 
al., 2014a, Trauffler et al., 2014b, Bondt et al., 2013, Jensen et al., 2012).  
 
For the DDDA, antimicrobial use is equal to the amount of active substances divided by the total 
weight of the number of livestock in the farm and mean authorised dosage. Other studies applied 
the same formula but called the unit of measurement differently as Animal Defined Daily Dose 
(ADDD) (Bos et al., 2013) and Daily Dose per animal year (nDDay) (Merle et al., 2012). One study 
used Defined Animal Daily Dosage (DADD), which is a measure established at the level of the active 
ingredient, route of administration and pharmaceutical form and not at the level of a specific 
antimicrobial class (Taverne et al., 2015). 
 
Product-related Daily Doses (PrDD) or Daily Product Dose (DPD) calculated the daily dose to an 
assumed factor of 0.8, correcting for the fact that the maximum doses are not used in every 
treatment (Ferner et al., 2014); this means only 80% of the maximal dosage of the active substances 
were administered per day per kilogram biomass (Trauffler et al., 2014a, Trauffler et al., 2014b). 
 
4.3 Antimicrobial use measured by daily dose per treatment period 
The Used Daily Dose (UDD) is the actual administered daily dose per kilogram biomass of a drug 
based on administered data reported by the farmer at farm level by a specific study. The formula for 
the UDD calculation is the weight of active substance divided by the number of treated animals, 
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multiplied by the average weight of animals and treatment duration. Three studies applied UDD 
(Carmo et al., 2017, Trauffler et al., 2014a, Trauffler et al., 2014b, Timmerman et al., 2006).  
One study quantified antimicrobial use as a Prescribed Daily Dose (PDD). This was calculated for 
each active pharmaceutical ingredient and for each prescription according to the amount of active 
pharmaceutical ingredient per prescription (mg) divided by the average weight of the animals 
multiplied by the number of animals and treatment period (Arnold et al., 2004).  
 
4.4 Antimicrobials use measured by daily dose per period at risk of treatment  
To compare each administered antimicrobial in specific individual species, the treatment incidence 
was used in five studies (Sjolund et al., 2016, Sjolund et al., 2015, Filippitzi et al., 2014, Callens et al., 
2012, Timmerman et al., 2006). It was defined as the number of pigs per 1,000 pigs that are treated 
daily with one ADD or UDD, which is equivalent to how many pigs per 1,000 pigs receive a dose of 
antimicrobials each day. In order to calculate the treatment incidence, the total UDD or ADD is 
divided by the treatment period, standard weight and population, then multiplied by 1,000. One 
study applied ‘treatment incidence’ rate for slaughtered pigs by dividing the number of ADD by 100 
slaughtered pigs at risk (Vieira et al., 2011). 
 
One study calculated ‘treatment frequency’ by using the sum of all UDD divided by population size. 
It identified how many days, on average, an animal in a herd is treated with one active 
pharmaceutical ingredient (van Rennings et al., 2015).  
 
<Figure 2> 
 
5. Volume of antimicrobial use 
As described above, this review uncovered a large variation in how antimicrobial use was measured, 
and the actual magnitudes of use. The annual antimicrobial use in pigs ranged from 20,000 kilograms 
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to72,300 kilograms at different farm and country levels. One study estimated 34 million kilograms of 
antimicrobials was found in medicated feed in pigs in China due to the massive number of livestock 
(Krishnasamy et al., 2015). However, more than one million kilograms were quantified in the studies 
in food animals in Germany (Hauck et al., 2014) and South Africa (Eagar et al., 2012) and about 63 
million kilograms globally (Van Boeckel et al., 2015). On the other hand, lower use was documented 
in Kenya where only 15,000 kilograms of antimicrobials were used in one year in all animal species 
(Mitema et al., 2001b). A wide range of volume per biomass was reported, ranged from 33.9 mg per 
biomass in Austria (Trauffler et al., 2014a) with about 400 mg per biomass in Japan (Hosoi et al., 
2014).  
 
The ADD varied from lower than one (Fertner et al., 2015) to 16 ADD (Taverne et al., 2015) in 
different phases of pig production and countries. Treatment incidence per 1,000 pigs at risk per day 
ranged from lower than 10 (Carmo et al., 2017, Sjolund et al., 2016, Sjolund et al., 2015) to more 
than 200 treatment incidences (Sjolund et al., 2016, Callens et al., 2012).  
 
However, careful interpretation across countries is needed as these measurements are not 
standardized. Also, the magnitudes of use are determined by the type of pig farms, animal 
demographic and the socio-economic context of a country. See details in table 3.  
 
<Table 3> 
 
Discussion   
 
Data sources   
Two main sources of data emerge from this review: national sales data and primary data collected 
through pig farm surveys. In many European countries, the national monitoring of antimicrobial 
AC
CE
PT
ED
 M
AN
US
CR
IPT
consumption relies on national sales data of pharmaceutical products, the disadvantage of sales 
data is the lack of information on which species they are being used for, the indication, dose and 
duration of treatment. Farm or pharmaceutical company surveys apply prospective longitudinal or 
cross-sectional studies which provide additional detailed use by species and production types 
(European Medicines Agency, 2013). One study applies bottom up approach for national 
consumption data estimate, it collects data from some herds and extrapolates to the national level 
(Filippitzi et al., 2014). However, this approach could be inaccurate as the sampled farms are not 
designed as national representative samples. 
 
Data sources for animal populations can be retrieved from total national data collection by 
government agencies such as slaughter house and production information, or it can be obtained 
from other sources such as the Association of Pig Farmers.  Data from international organizations 
such as the FAOSTAT database hosted by the Food and Agriculture Organization is another source of 
the size of animal populations (Krishnasamy et al., 2015, Van Boeckel et al., 2015). Even though, 
FAOSTAT information is limited such as estimates for non-responses and incomplete report, and the 
lack of granularity on number of animal of species; it can be applied when data at the country is not 
available. Using different weights of animals at treatment across studies resulted in substantial 
differences in use and hinders comparability (Carmo et al., 2017, Dupont et al., 2016).  
 
Methods and units of measurement  
This systematic review describes methods for measuring antimicrobial use. All the studies in the 
review were conducted after 2000. Most of the literatures on the pattern of use of antimicrobials 
are derived from high-income countries in the European region; while very few studies were 
conducted in Asia and Africa, which applied the traditional measurement by weight of active 
substance per animal weight.  
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This review indicates that there is no global harmonised system for measuring antimicrobial use in 
animals.  The proliferation of indicators using different measurements of both numerators and 
denominators hampers cross-country comparisons.  
  
Several studies reported the quantity of use in kilograms of active ingredient without denominator 
data. Though simple, its main limitation is that it does not give any indication of intensity of use.  To 
address this deficiency, measurements of use per weight have been widely used. However, using 
kilogram of active ingredients does not take into account the differences in drug strengths, doses 
administered and pharmacokinetics. The use of higher strengths, dosage and more treatment days 
led to higher antimicrobial use than those which were applied at lower strengths and dosage (van 
Rennings et al., 2015).  
 
There is also a large variation in strengths and dosages of antimicrobials use in human health. In 
order to standardise the measurement, the DDD was developed and is now used globally to measure 
antimicrobial consumption in humans with standardised reporting by DDD per 1000 inhabitant-days. 
This facilitates international comparison on antimicrobial use (Natsch et al., 1998). However, a 
similar universal standardised unit of DDD measurement has not yet been developed for veterinary 
antimicrobial agents; hence different countries have established their own national ADD-value, 
based upon medicine specifications registered by their National Regulatory Authorities.  The 
different ADD-values for veterinary medicines hampers cross country comparisons, as using different 
sets of ADD-values affected the estimate of use (Dupont et al., 2016, Taverne et al., 2015).  
Moreover, there are not only different units of measurement, but countries also name their 
measurement differently, such as ADD in Denmark (Jensen et al., 2004) and ADDD in Netherlands 
(NETHMAP and MARAN, 2013). 
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There has been an attempt to establish a consensus on DDDA for each active substance and 
administration route for veterinary antimicrobial products authorized in four European countries 
(Postma et al., 2015); this effort has yet to scale up to all European countries. Another approach to 
calculate the daily dose is by using an actual dose administered to animal. Instead of using ADD-
value, a DPD is proposed to by adjusting the recommended maximum daily dose by a factor of 0.8 of 
maximal dose for specific medicinal products; assuming that the maximum doses are not used in 
every treatment (Ferner et al., 2014, Trauffler et al., 2014a, Trauffler et al., 2014b).  
 
To differentiate antimicrobial use between herds, antimicrobial per treatment periods were 
calculated based on real use data at farm level. In 2006, a measurement called UDD was introduced 
firstly in a study in pig farms (Timmerman et al., 2006). The UDD was calculated based on the 
definite number of treated animals in a treatment period and the dosages of antimicrobials to 
animals in farms; the UDD avoids differences between ADD-values and supports comparison of use 
across countries and across studies. Moreover, the ratio between UDD/ADD reflects the 
appropriateness of dosing where the higher the ratio, the more excessive the use. Another 
measurement of antimicrobial use that takes into account the treatment period was PDD; it reports 
antimicrobial use by antimicrobial prescription. PDD also shows the veterinarian’s prescribing 
pattern. However, antimicrobial prescription is not always equal to the actual antimicrobial 
administration (Chauvin et al., 2001).  
 
There are several methods that relate to the association between the actual volume of specific 
antimicrobials used in a specific time period such as ‘treatment frequency’ (van Rennings et al., 
2015) and ‘treatment incidence rate’ (Vieira et al., 2011). Furthermore, the ‘treatment incidence’ 
has been introduced for a comparison of data between farms, considering the period at risk of 
treatment (Sjolund et al., 2016, Sjolund et al., 2015, Filippitzi et al., 2014, Callens et al., 2012, 
Timmerman et al., 2006). The treatment incidence rate can compare the antimicrobial use per 
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animal species and details of antimicrobial use in terms of dosage and route of administration which 
can be compared between herd and production types. It can be calculated based on both ADD-
values or UDD. However, comparison of ‘treatment incidence’ to other studies should be done with 
caution when ADD-value is used (Sjolund et al., 2015).  
 
The wide variation in methods and indicators across the studies, and the relative lack of swine-
specific data prevent this review from making valid comparisons of antimicrobial use in swine 
production or documenting trends.  
 
European experiences and international recommendations  
In European countries, the European Medicines Agency (EMA) established the ESVAC project in 
2009. The antimicrobial consumption reported by ESVAC members is comparable across countries 
by using a standardized measurement of mg of active ingredient per population correction unit 
(mg/PCU). The total volume of antimicrobials used in 30 European countries was 8,361.3 tonnes of 
active ingredients or 135.5 mg/PCU on an average of consumption in food producing animals in 2015 
(European Medicines Agency, 2015). 
 
The ESVAC project has contributed significantly to the standardised methods for antimicrobial 
consumption in 30 countries in Europe and has also spill over effects to developing countries, in 
particular Thailand (Tangcharoensathien et al., 2017). In addition to the current reporting of mg per 
PCU, the ESVAC project has established standardised units of measurement in three major animal 
species (pigs, cattle and broilers) called Defined Daily Dose (DDDvet) and Defined Course Dose 
(DCDvet). It aims to harmonize and standardize reporting data on veterinary antimicrobial 
consumption across European countries. The values are based on an assumed average DDDvet or 
DCDvet of active substance, which take into account differences in dosing, pharmaceutical forms 
and routes of administration used by these three species (European Medicines Agency, 2015). 
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 To rectify the weakness of national sales data, in 2013, the EMA recommended that countries 
conduct  farm surveys of veterinary prescriptions or antimicrobial administration records in the 
logbooks kept by farmers, specific for different species (see ESVAC guidelines of data collection at 
farm level) (European Medicines Agency, 2013). Though this additional data collection from farms 
demands substantial resources, infrastructure development and enforcement of veterinary 
prescriptions at farm level, the benefit is high as it provides accurate information on antimicrobial 
use by classes and animal species and indications, and evidence can be used to facilitate the 
development of specific interventions and improve the specific training and education in 
veterinarians and farmers.  
 
To date, the OIE has also relied on antimicrobial sales data as indicators of actual use, and also 
recommends that OIE member countries to collect and report data on quantity of antimicrobial 
consumption in kilogram of antimicrobial agents for different types of indication (therapeutic use or 
growth promotion), different animal species group and different routes of administration. In the 
second OIE annual report in 2017 on the use of antimicrobial agents intended for use in animals, OIE 
recommended to use animal biomass as a denominator so that the quantitative data on 
antimicrobial agent can be compared among countries. Animal biomass is calculated as the total 
weight of the live domestic animals, used as a proxy to represent those likely to have exposed to the 
quantities of antimicrobial agents reported (World Organisation for Animal Health (OIE), 2017).   
 
From the review, data of the volume of antibiotic use in low- and middle-income countries are 
limited while these countries have a large livestock production. Only three studies are included in 
this review, which includes Kenya (lower-middle-income economies), and China and South Africa 
(upper-middle-income economies). Data from South Africa and Kenya was reported in kilogram of 
antimicrobials used in all livestock. Total antibiotics were calculated by the review of sales of 
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pharmaceutical product. Whereas, the study in China reported antimicrobials in medicated feed by 
estimation. The quantity of antimicrobials was calculated by using antimicrobial utilization data from 
the US livestock production. This review indicates an urgent need to build up national capacity to 
develop system which monitors antimicrobial consumption in LMIC. The monitoring systems of 
antimicrobial consumption can be developed in a phased manner (Schar et al., 2018).  
 
Policy utilities  
Data on antimicrobial usage is needed for a number of reasons such as monitoring time trends of 
use and assessing the effectiveness of interventions. Ideally it should be disaggregated by different 
antimicrobial classes in particular the critically important for human health. It can also be used to 
investigate the association between the magnitude of use and bacterial resistance (Collineau et al., 
2017, Schar et al., 2018).  
 
Conclusion  
We systematically reviewed the peer-reviewed literatures on the methods and measurements for 
antimicrobial use in pigs globally. Ten different units of measurement were identified from 25 
studies of high- and medium-quality studies; which vary greatly in term of objectives, data sources 
and units of measurement both numerators and denominators. The non-homogeneity of the unit of 
measurement limits the cross-study comparative analysis. Additionally, different levels of data such 
as from farm surveys and national sales data used by these studies also produce different magnitude 
of use across studies.  
 
Recommendations   
Given the importance of measuring antimicrobial use in monitoring progress of policies in optimizing 
use, at a minimum, all developing countries should develop macro-level monitoring using national 
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sales data and report consumption by milligram of active ingredients per biomass, while at the same 
time, when there are improved capacities, gradually develop sentinel sites which capture 
prescription of antimicrobial use by species with the application of DDDvet and DCDvet. The EMA 
initiative on standardised units of measurement in three main animal species using DDDvet and 
DCDvet, should be scaled up in Europe and can be applied by developing countries in responses to 
the GAP-AMR which calls for monitoring and optimizing antimicrobial use.  
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APPENDIXES 
Table A1 Variables assessed in the study 
Variables Results 
1. Context variables Author, year of publication, year of study, title, journal, geographical 
area, objective 
2. Methodology variables 2.1 Research (Observational study: cohort studies/case–control studies/ 
cross-sectional surveys/routine-data-based studies); national report  
  2.2 Data source: primary data (survey, interview) from pig producer, 
veterinarian; secondary data from company (sales data), veterinarian 
(prescription data), government, level of data (national or specific small-
scale farm level) 
2.3 Sampling technique, if it is a primary data collection: simple random 
sampling, stratified sampling, cluster sampling, systematic sampling, 
Probability Proportional to Size (PPS), quota sampling, convenience 
sampling, purposive sampling, self-selection sampling, snowball sampling 
  2.4 Sample size: number of respondent, response rate (%) 
 2.5 Methods for antimicrobial use measurement and indicators  
Comments (including 
strengths, weaknesses) 
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Table A2 Quality assessment of included studies 
Author, year 
Clearly 
focused issue 
  Method  Result   Application   Rank* 
  
Appropr-       
iateness 
Recruitment  
Bias 
reduction 
Data 
collection 
Number 
of 
participa
nts 
 
Prese
ntatio
n 
Sufficiently 
rigorous 
Clear 
statement 
finding 
 
To local 
population 
Research 
value 
  
2016                 
Carmo et al. (Carmo et 
al., 2017) 
Y  Y CT CT Y Y  Y Y Y  Y Y  H 
Dupont et al. (Dupont et 
al., 2016) 
Y  Y Y Y Y Y  Y Y Y  Y Y  H 
Sjolund et al. (Sjolund et 
al., 2016) 
Y  Y N N Y Y  Y Y Y  Y Y  H 
2015                 
Krishnasamy et al. 
(Krishnasamy et al., 
2015) 
Y  N N CT CT CT  Y N Y  Y Y  M 
Rennings et al. (van 
Rennings et al., 2015) 
Y  Y Y N Y Y  Y Y Y  Y Y  H 
Sjolund et al. (Sjolund et 
al., 2015) 
Y  Y Y N Y Y  Y Y Y  Y Y  H 
Taverne et al.  (Taverne 
et al., 2015) 
Y  Y Y Y Y Y  Y Y Y  Y Y  H 
Van Boeckel et al. (Van 
Boeckel et al., 2015) 
Y  Y N Y CT CT  Y CT Y  Y Y  M 
2014                 
Ferner et al. (Ferner et 
al., 2014) 
Y  Y N N Y N  N N Y  Y Y  M 
Fertner et al (Fertner et 
al., 2015) 
Y  CT N N Y N  Y Y Y  Y Y  M 
Filippitzi et al. (Filippitzi 
et al., 2014) 
Y  Y CT N CT CT  Y Y Y  Y Y  M 
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Hauck et al. (Hauck et 
al., 2014) 
Y  Y Y CT CT Y  Y Y Y  Y Y  H 
Hosoi (Hosoi et al., 
2014) 
Y  Y CT N N N  Y Y Y  Y Y  M 
Trauffler et al. (a) 
(Trauffler et al., 2014a) 
Y  Y N N Y N  Y Y Y  Y Y  M 
Trauffler et al. (b) 
(Trauffler et al., 2014b) 
Y  Y N N Y N  Y Y Y  Y Y  M 
2013                 
Bondt et al. (Bondt et 
al., 2013) 
Y  Y Y CT CT Y  Y Y Y  Y Y  H 
Bos et al (Bos et al., 
2013)  
Y  Y Y Y Y Y  Y Y Y  Y Y  H 
2012                 
Callen et al.  (Callens et 
al., 2012) 
Y  Y Y N Y Y  Y Y Y  Y Y  H 
Eagar et al. (Eagar et al., 
2012) 
Y  Y N N Y N  Y Y Y  Y Y  M 
Merle et al. (Merle et 
al., 2012) 
Y  Y N Y Y Y  Y Y Y  Y Y  H 
Jensen et al. (Jensen et 
al., 2012) 
Y  Y N N Y Y  Y Y Y  Y Y  H 
2011 
Vieira et al. (Vieira et 
al., 2011)  
Y  Y Y Y Y Y  Y Y Y  Y Y  
 
H 
2006 
Timmerman et al. 
(Timmerman et al., 
2006) 
Y  Y Y Y Y Y  Y Y Y  Y Y  H 
2004 
Arnold et al. (Arnold et 
al., 2004) 
Y  Y Y N Y Y  Y Y Y  Y Y  
 
H 
AC
CE
PT
ED
 M
AN
US
RI
PT
2001 
Mitema et al. (Mitema 
et al., 2001a) 
Y  Y CT N Y CT  Y N Y  Y Y  
 
M 
 
*score >75 = high (H), 50-74 = medium (M) and <50 = low (L) 
CT: Cannot tell  
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Table A3 Summary of unit of measurement from included studies 
Definition and unit of 
measurement  
Numerator Denominator Variable Reference 
Amount of 
antimicrob
ials 
Dose Animal 
weight  
Number 
of 
animals 
Treatme-
nt period 
Additional 
variable 
 
By population 
A. Volume of antimicrobial 
use (kilogram) 
1.Number of animals  
2. Estimated (medicated) 
feed) consumed per day 
3.Duration that swine 
received antimicrobial  
4. Dose of antimicrobial  
NA Y 
(medicate
d feed) 
Dose in 
the feed 
N Y Y N Krishnasamy, 2015 
B. Volume of antimicrobial 
use per biomass (mg/PCU; 1 
PCU = 1 kilogram of 
biomass of livestock and 
slaughtered animals)   
Active pharmaceutical 
ingredient (sold, 
prescription) 
1. Number of slaughtered 
animals  
2. Number of livestock  
3. Number of 
imported/exported animals  
4. AW  
Y N N Y N Average 
weight at 
treatment 
Carmo, 2017 
(mg/PCU) Active substance Numbers of live animals x (1+ 
production period) x ratio of 
carcass weight to live weight of 
animals 
Y N N Y N Production 
period, 
ratio of 
carcass/ live 
weight  
Van Boeckel, 2015 
 (mg/biomass) Active substance (sold) Carcass weight Y N Carcass  N N N Hasoi, 2015 
Daily dose and weight at treatment 
C. Product-related Daily 
Doses (PrDDkg) or Daily 
Product Dose (DPD) 
Active substance 
(prescription)/ 80% of 
maximal dose 
 Standard weight  
x population 
Y 80% of 
maximal 
dose 
Std. 
weight 
Y 
 
N N Trauffler, 2014a; 
Trauffler, 2014b; 
Ferner, 2014 
D. Animal Daily Dose (ADD) 
(mg/kg bodymass/day)  
Active substance 
(administered/ 
prescription)/ ADD-value 
(average maintenance 
dose per day per kg 
Standard weight 
x number of animal 
Y Mainten
ance 
dose 
Std. 
weight 
Y N N Dupont, 2016; Taverne, 
2015;  Fetner, 2015; 
Ferner, 2014; Trauffler, 
2014a; Trauffler, 2014b; 
Bondt, 2013; Jensen, 
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animal of a drug use for 
main indication in the 
target species) 
2011 
Definition and unit of 
measurement  
Numerator Denominator Variable Reference 
Amount of 
antimicrob
ials 
Dose Animal 
weight  
Populati
on 
Treatme-
nt period 
Additional 
variable 
 
 ADD-LU (livestock unit; 
LU) (mg/500 kg LU 
biomass/day) 
ADD x 500 NA N N N N N ADD Ferner, 2014 
 Number of animal daily 
doses per livestock unit 
(nADDsLU)  
ADD-LU Number of treated LUs (total 
number of LU produced in one 
year by all farm, in which at 
least treatment was recorded) 
N N N N N N Ferner, 2014 
E. Defined Daily Doses per 
animal year (DDDA) or 
Animal Defined Daily Dose 
(ADDD) or Daily Dose per 
animal year (nDDay) 
Active substance 
(prescription) 
Recommended dose 
x total animal mass that can be 
treated for one day with the 
supplied antimicrobials  
x mean total weight (kilogram ) 
of animals on the farm   
Y Recomm
ended 
dose 
Mean 
weight  
Y N N Taverne, 2015; Bos, 
2013; Merle, 2012 
Daily dose and treatment period 
F. Used Daily Doses per kg 
biomass (UDDkg) (mg/ 
kilogram biomass/ day) 
Active substance 
(administered) 
Number of treated animals  
x Standard weight (kilogram )  
x Treatment duration (days) 
Y N Std. 
weight 
Y Y N Timmerman, 2006; 
Trauffler, 2014a; 
Trauffler, 2014b 
G. Prescribed Daily Dose 
(PDD) (mg/kg* day)   
Active substance 
(prescription) 
Average weight of the animals  
x number of animals (n)   
x treatment period (days)) 
Y N Avg. 
weight  
Y Y N Arnold 2004 
H. Treatment frequency  UDD Population size N N N Y N UDD Rennings, 2015 
I. Treatment incidence rate ADD Sum of delivered animals in the 
period * 112 (112= days of 
fattening period) OR 100 
slaughter pig-days at risk 
N N N Y N N Vieira, 2012 
Daily dose and period at risk of being treated 
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J. Treatment incidence- 
DDA (TI-DDA), UDDA (TI-
UDDA) 
DDA/ UDD(mg/kg) x 1,000 
population 
 Y N Avg. 
weight 
Y Y UDD, 
ADD 
Sjolund, 2016; Sjolund, 
2015; Filippitzi, 2014; 
Callens 2014; 
Timmerman 2006 
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Annex 1 
 
I.  Search Strategy 
Structured Database Search (Search terms and results) 
o MEDLINE: N= 401 articles 
- (antibiotic or antimicrobial).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier, synonyms] 
(251,939) 
- ("use" or "utilisation" or "consume*" or "practice" or "administration" or "oral" or 
"feed" or "injection" or "amount" or "quantit*" or "qualit*").mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier, synonyms] (5,584,129) 
- ("livestock" or "swine" or "pig" or "farrow" or "weaner" or "sow").mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] (285,470) 
- ("measurement" or "indicator" or "surveillance" or "survey" or "report" or 
"method").mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms] (3,766,673) 
 
o Sciencedirect: N= 636 articles 
"Antibiotic" AND ("swine" OR “pig”) AND ("use" OR “survey” OR “surveillance” OR 
“consumption”) 
AC
CE
PT
ED
 M
AN
US
CR
IPT
Filter: Topics, "pig”, “animal”; Content type, "Journal” 
 
o Scopus: N= 630 articles 
(TITLE-ABS-KEY (antibiotic OR  antimicrobial  OR  antibacterial )  AND  TITLE-ABS-KEY ( 
livestock  OR  swine  OR  pig  OR  farrow  OR  weaner  OR  finisher  OR  sow )  AND  TITLE-
ABS-KEY (use OR utilisation OR consume* OR consumption OR practice OR administration 
OR provision) AND  TITLE-ABS-KEY ( measure*  OR  indicator  OR  surveillance  OR  survey  
OR  monitor ) )  
 
o Web of Science: N= 691 articles 
TOPIC:(antibiotic OR antimicrobial OR antibacterial) AND TOPIC: (livestock OR swine OR 
pig OR farrow OR weaner OR finisher OR sow) ANDTOPIC: (use OR utilisation OR 
consume* OR consumption OR practice OR administration OR 
provision) AND TOPIC: (measure* OR indicator OR surveillance OR survey OR monitor) 
Filter:  DOCUMENT TYPES: (ARTICLE) AND WEB OF SCIENCE CATEGORIES: (VETERINARY 
SCIENCES OR MICROBIOLOGY OR AGRICULTURE DAIRY ANIMAL SCIENCE) 
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Figure 1 Flow diagram of the review process  
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Potential relevant studies identified through database and source searching (2,362) 
- Electronic database searching (MEDLINE [401], Sciencedirect [636], Scopus [630], 
Web of Science [691] 
- Additional searching from citations [4] 
Records excluded (2,272) due to the following reasons:  
- Duplicates removed [14] 
- Screen title and abstract by comparison with 
keywords [2,258] 
Full text retrieved for screening (n=90) 
Records excluded (53) on the basis of  
- No reference to any key aspect of pattern or volume 
of antimicrobial use in pigs [24] 
- Inappropriate study design: review, clinical research, 
pharmacokinetic, etc. [17] 
- Focus on laboratory study or on human health 
antimicrobial activity, relationship with AMR, specific 
disease related to drug recommendation [9] 
- Measurements of antimicrobial levels in farm waste, 
feces and environment, residue in animal [3] 
- products 
Full-text articles assessed for eligibility (n=37) 
Records excluded (12) on the basis of 
- No report on pattern or volume of antimicrobial 
use in pigs [7] 
- Inappropriate study design [2] 
- Focus on laboratory study or on human health 
antimicrobial activity, relationship with AMR, 
specific disease related to drug recommendation 
[3] 
- Low level of quality from assessment [0] 
-  
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Denominator 
 
 
Used Daily Dose 
(UDD)**, Prescribed 
Daily Dose (PDD)**  
(mg/kg/day)  
(Trauffler, 2014a; Trauffler, 
2014b; Timmerman, 2006 
Arnold, 2006) 
 
Numbers of live animals x  
(1+ production period) x ratio of 
carcass weight to live weight of 
animals  
(Van Boeckel, 2015) 
 
 
Sum of  
1. Number of animals slaughtered × 
estimated weight at treatment.  
2. Number of livestock × estimated 
weight at treatment.  
3. Number of animals transported 
(net export to other countries) × 
estimated weight at treatment. 
(kilogram per population correction 
unit, PCU) 
(Carmo, 2017; Filllipitzi, 2014; 
Trauffler, 2014a; Trauffler, 2014) 
 
 
Animal Daily Dose (ADD) 
(mg/kg)  
 (Dupont, 2016; Fetner, 
2015; Taverne, 2015; 
Ferner, 2014; Trauffler, 
2014a; Trauffler, 
2014b; Bondt, 2013; 
Jensen, 2011) 
 
per animal weight  
 
 
Defined Daily Doses per 
animal year (DDDA) or 
Animal Defined Daily 
Dose (ADDD) or Daily 
Dose per animal year 
(nDDay) 
(mg/kg)  
   (Taverne, 2015; Bos, 2013;  
Marle, 2012) 
 
/80% of maximal dose  
 
/ADD value 
 
/Mean authorised 
dose  
 
Daily Product Dose 
(DPD) or Product-
related Daily Doses 
(PrDD) 
(mg/kg)  
(Ferner, 2014; Trauffler, 
2014a; Trauffler, 2014b) 
 Standard weight  
x number of treated animals       
x treatment period (days)  
  
Standard weight x population 
Treatment incidence (TI: TI-ADD, TI-UDD), Treatment incidence rate 
(per 1,000 pigs at risk per day) 
(Sjolund, 2016; Sjolund, 2015; Filippitzi, 2014; Callens 2014; Vieira, 2012; Timmerman 2006) 
 
ADD/ UDD x 1,000 pigs at risk 
 
 
Numerator 
 Quantity of antimicrobials: sales data, prescription data 
(mg of active pharmaceutical ingredient) 
By daily dose per weight at treatment 
 
 
Treatment frequency (TF)*  
 (van Rennings, 2015) 
UDD/ number of population size 
By daily dose per treatment period 
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Figure 2 describe the ten different measurements, categorised in four groups 
*Additional measurement: calculated from ADD, UDD; **Actual consumption data which calculated antimicrobial per a number of treated animal 
 
 
 
By daily dose per period at risk of treatment 
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 Table 1 Search terminology to be used in literature review. 
  Search term 
I antimicrobial (Free text) OR antimicrobial (MeSH term) OR antibacterial (Free text) OR 
antibacterial (MeSH term) OR antibiotic (Free text) OR antibiotic (MeSH term) 
II livestock (Free text) OR swine (Free text) OR pig* (Free text) OR farrow (Free text) OR 
weaner (Free text) OR finisher (Free text) OR sow (Free text) 
III use (Free text) OR utilisation (Free text) OR consum* (Free text) OR practice (Free text) 
OR administration (Free text)  
IV measure* (Free text) OR indicator (Free text) OR surveillance (Free text) OR survey 
(Free text) OR monitor (Free text) 
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Table 2 Characteristics of included studies 
Characteristics N=25 
Quality assessment (mean)   
Published year   
2000-2010 3 (12%) 
2010-2016 22 (88%) 
Geographic area   
Europe 20* (80%) 
Africa 2 (8%) 
Asia 2 (8%) 
Global  1 (4%) 
Quality assessment  
High (>75%) 15 (60%) 
Moderate (50-74%) 10 (40%) 
Unit of analysis   
National level  11 (44%) 
Farm level 14 (56%) 
Data collection on antimicrobial use    
Farm based survey  7 (28%)  
National data  6 (24%) 
Prescription data  4 (16%) 
Pharmaceutical product sold review  4 (16%) 
Mixed method (>1 data source)  3 (12%) 
Data from another country** 1 (4%) 
Report by type of antimicrobials  
Sum of all antimicrobials 3 (12%) 
Disaggregated by classes 22 (88%) 
Report by animal species  
Sum of antimicrobials in all animal species 5 (20%) 
Specific in pig/ disaggregated by animal species 20 (80%) 
Unit of measurement used  (N=40)  
- Volume  9 (23%) 
- Volume per biomass  6 (15%) 
- Daily Product Dose (DPD)  3 (8%) 
- Animal Daily Dose (ADD)   8 (20%) 
- Defined Daily Doses per Animal year (DDDA)  3 (8%) 
- Used Daily Dose (UDD)   3 (8%) 
- Prescribed Daily Dose (PDD)  1 (3%) 
- Treatment incidence rate  1 (3%) 
- Treatment frequency  1 (3%) 
- Treatment incidence  5 (13%) 
*including two multi-country studies  
** the study estimated the quantity of antimicrobials used in animal feeds in China by using 
antimicrobial utilization data from the US livestock production.  
Table 3 Summary antimicrobial usage data from studies included in this review  
Unit of measurement  Antimicrobial usage data 
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 3 
Volume of active substances 
and volume per animal weight 
- 67,423-72,300 kg of active substances;  
110-160, 86.3-124.4, 54.9-178.6, 34-143.8 mg/biomass (different methods 
for calculation) (Switzerland) (12) 
- 34 million kg of antimicrobials in medicated feed (China) (Krishnasamy et 
al., 2015) 
- 20,373.6 kg of antimicrobials (in study farms) (Germany) (van Rennings et 
al., 2015) 
- 63,151, 000 kg (Global level) (Van Boeckel et al., 2015)* 
- >5,400 kg of active substances (Austria) (Ferner et al., 2014)* 
- 222,500 kg of active substances; 
 137 mg/biomass (Belgium) (Filippitzi et al., 2014)* 
- 1,706 tons of active substances (2011) and 1,619 tons (2012) (Germany) 
(Hauck et al., 2014)* 
- 392 to 423 mg/ biomass (Japan) (Hosoi et al., 2014) 
- 33.89 mg/ biomass/year (Austria) (Trauffler et al., 2014a, Trauffler et al., 
2014b) 
- 1,538,443 kg of antimicrobials (South Africa)* 
- 31,622 kg of antimicrobials (Germany) (Merle et al., 2012) 
- 14,594 kg of antimicrobials per year (Kenya) (Mitema et al., 2001)* 
Volume by daily dose per  
weight at treatment (ADD, 
DDDA, DPD) 
- 9.4, 10.4, 11.6 ADD (Denmark) (13) 
- 0.6-7.37 ADD (Denmark) (Fertner et al., 2015) 
- 11.78-19.20 DDDA; 11.57-16.0 and 10.43-15.32 ADD in sow/piglet farms 
and finisher farms (Netherlands and Denmark) (Taverne et al., 2015) 
- DPD-LU 631,939; ADD-LU 576,242(Austria) (Ferner et al., 2014)* 
- 2.51 DPD; 1.95 ADD (Austria) (Trauffler et al., 2014a, Trauffler et al., 2014b) 
- 19 ADD in Netherlands and 14 ADD in Denmark (27) 
- 16.9 DDA and 9.6 DDDA in production and slaughtered pig farms 
(Netherlands) (Bos et al., 2013) 
- 60.86 DDDA for piglets, 28.60 DDDA for fattening pigs, 2.89 DDDA for sows 
Germany) (Merle et al., 2012) 
- 1.40-2.14 ADD for sows, 5.02-5.90 ADD for weaners, 1.12-1.37 ADD for 
finishers (Denmark) (Jensen et al., 2012) 
Volume by daily dose per 
treatment period  
 (UDD, PDD, Treatment 
incidence rate, Treatment 
frequency) 
-  Treatment frequency: 0.86 days for sows, 14.74 days for piglets, 6.62 days 
for weaners and 3.67 for fattening pigs (Germany) (van Rennings et al., 
2015) 
- 4.88 UDD (Austria) (Trauffler et al., 2014a, Trauffler et al., 2014b) 
- Treatment incidence rate: Tetracycline 0.28- 0.70, Macrolide 0.40-0.44 
(Denmark) (Vieira et al., 2011) 
- 3.3-6.1 PDD (Switzerland) (Arnold et al., 2004) 
 Volume by daily dose per 
period at risk of treatment 
-  TI-ADD (per 1,000 pigs at risk per day): Belgium: 176 (suckling), 406 
(weaned), 33 (fattening), 143 (growing), 16 (breeding) 
France: 59 (suckling), 374 (weaned), 7 (fattening), 108 (growing), 22 
(breeding)  
Germany: 245 (suckling), 633 (weaned), 53 (fattening), 243 (growing), 42 
(breeding)  
Sweden: 76 (suckling), 21 (weaned), 6 (fattening), 23 (growing), 11 
(breeding) (Sjolund et al., 2016) 
- TI-ADD (per 1,000 pigs at risk per day): 54.7 (suckling), 6.2 (weaned), 2.8 
(fattening), 14.3(growing), 8.4 (breeding) (Sweden) (Sjolund et al., 2015) 
- TI-ADD (per 1,000 pigs at risk per day): 235.8, TI-UDD 200.7 (2012) (Used 
Callen data) (Belgium) (Filippitzi et al., 2014) 
- TI-ADD (per 1,000 pigs at risk per day): 235.8, TI-UDD 200.7 (Belgium) 
(Callens et al., 2012) 
- TI-ADD (per 1,000 pigs at risk per day): 178.1, TI-UDD 170.3 (Belgium) 
(Timmerman et al., 2006) 
* Data combined other species 
AC
CE
PT
E
 M
AN
US
CR
IPT
19 September 2018 
 4 
ADD: Animal Daily Dose, DDDA: Daily Doses Animal, DPD-LU: Daily Product Dose, LU: livestock unit, 
PDD: Prescribed Daily Dose, TI-ADD: Treatment incidence for Animal Daily Dose, TI-UDD: Treatment 
incidence for Used Daily Dose   
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